Abstract
Cancer has been one of the most complex diseases over the decade with standard methods of therapy such as chemotherapy, radiotherapy, and surgery. However, there are several limitations to such treatments. The cancer patients become resistant to the current conventional cancer therapies and treatment regimens which lead to progression instead of regulation. The ability of chemotherapeutic agents to reach the tumor tissue is restricted due to its passage through the cellular membrane by passive transport. Therefore new therapies need to be improved using microbes as adjuvant with current immunotherapy. This will prove to be a promising approach to combat disease progression leading to better regulation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
